Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis

Background. Atrial fibrillation (AF) is the most common serious cardiac rhythm disturbances and is responsible for substantial morbidity and mortality in general population. Hypertension is the most prevalent and potentially modifiable risk factor for AF. This study is aimed at evaluating the effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haotian Ma, Hongcheng Jiang, Jing Feng, Yong Gan
Formato:	Artículo
Lenguaje:	English
Publicado:	Hindawi-Wiley 2021-01-01
Colección:	Cardiovascular Therapeutics
Acceso en línea:	http://dx.doi.org/10.1155/2021/6628469

Ejemplares similares

Angiotensin&nbsp;II receptor blockers in the prevention of complications from atrial fibrillation
por: Gerald V Naccarelli, et al.
Publicado: (2009-09-01)

Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention
por: Cesare Cuspidi, et al.
Publicado: (2008-02-01)

A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
por: Ji-Guang Wang
Publicado: (2009-07-01)

Long-term observation of fibrillation cycle length in patients under angiotensin II receptor blocker therapy for chronic atrial fibrillation
por: Jun Kishihara, et al.
Publicado: (2012-02-01)

Left Atrial Function in Different Modes of Heart-Rate Lowering Therapy with Beta-Blockers in Patients with Recurrent Atrial Fibrillation and Hypertension
por: E. V. Kokhan, et al.
Publicado: (2021-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
por: O. M. Drapkina, et al.
Publicado: (2014-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
por: O. M. Drapkina, et al.
Publicado: (2014-07-01)

Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgery
por: Weiss Michael J, et al.
Publicado: (2010-02-01)

Angiotensin‐Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New‐Onset Atrial Fibrillation After Acute Myocardial Infarction
por: Gorav Batra, et al.
Publicado: (2017-03-01)

Termination of Aconitine-Induced Atrial Fibrillation by the KACh-Channel Blocker Tertiapin: Underlying Electrophysiological Mechanism
por: Kazumasa Suzuki, et al.
Publicado: (2014-01-01)

Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation
por: Nicole Habel, et al.
Publicado: (2023-06-01)

Effect of β-blockers on the risk of atrial fibrillation in patients with acute myocardial infarction
por: Antonio Eduardo Pesaro, et al.
Publicado: (2010-01-01)

Calcium channel blockers, more than diuretics, enhance vascular protective effects of angiotensin receptor blockers in salt-loaded hypertensive rats.
por: Eiichiro Yamamoto, et al.
Publicado: (2012-01-01)

Organization of atrial fibrillation using a pure sodium channel blocker: Implications of rotor ablation therapy
por: Tadafumi Nanbu, et al.
Publicado: (2023-06-01)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
por: Hyun Woong Lee
Publicado: (2014-12-01)

Correction: Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats
Publicado: (2013-01-01)

Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes
por: Nishida Yayoi, et al.
Publicado: (2012-05-01)

The haemodynamic changes associated with treatment of new-onset atrial fibrillation with amiodarone or beta blockers
por: Bedford, J, et al.
Publicado: (2021)

Decreased Mortality with Beta-Blocker Therapy in HFpEF Patients Associated with Atrial Fibrillation
por: Yanhua Yang, et al.
Publicado: (2020-01-01)

Acute Management of Paroxysmal Atrial Fibrillation with Intravenous Flecainide plus Oral Beta-Blockers
por: Athanasios Kartalis, et al.
Publicado: (2024-06-01)

Which beta-blocker should be used for the prevention of postoperative atrial fibrillation in cardiac surgery? A multi-treat
por: Mohamed Zeinah, et al.
Publicado: (2016-06-01)

Novel beta-blocker pretreatment prevents alcohol-induced atrial fibrillation in a rat modelKey Findings
por: Hebah Hassan, BS, et al.
Publicado: (2020-06-01)

The use of angiotensin receptor blockers in dementia prevention
por: Jordana de Araujo Müller, et al.
Publicado: (2023-09-01)

Effect of angiotensin receptor-neprilysin inhibitor on atrial electrical instability in atrial fibrillation
por: Tianyu Zhu, et al.
Publicado: (2022-12-01)

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: An individual-patient data meta-analysis
por: Kotecha, D, et al.
Publicado: (2014)

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
por: Kotecha, D, et al.
Publicado: (2014)

Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction
por: Akif Arslan, et al.
Publicado: (2016-01-01)

Effects of Angiotensin Receptor Blockers on Apelin and Visfatin in Hypertension
por: Mina Mohammed, et al.
Publicado: (2024-06-01)

Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
por: Yen-Chung Lin, et al.
Publicado: (2017-01-01)

COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT)
por: O. V. Dralova, et al.
Publicado: (2016-01-01)

Effect of angiotensin II receptor blockers and calcium antagonists on cognition
por: O. D. Ostroumova, et al.
Publicado: (2016-12-01)

β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation—a meta-analysis
por: Tianyu Xu, et al.
Publicado: (2019-06-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
por: M. A. Maksimova, et al.
Publicado: (2015-09-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
por: M. A. Maksimova, et al.
Publicado: (2015-09-01)

Real-world efficacy of fimasartan vs. other angiotensin receptor blockers in combination with calcium channel blockers: a nationwide cohort study
por: Huijin Lee, et al.
Publicado: (2024-10-01)

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic
por: Volpe M, et al.
Publicado: (2012-06-01)

Differential Effects in Cardiovascular Markers between High-Dose Angiotensin II Receptor Blocker Monotherapy and Combination Therapy of ARB with Calcium Channel Blocker in Hypertension (DEAR Trial)
por: Kenichiro Kinouchi, et al.
Publicado: (2011-01-01)

Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up
por: Han Saem Jeong, et al.
Publicado: (2021-01-01)

Lowering serum homocysteine in H-type hypertensive patients with atrial fibrillation after radiofrequency catheter ablation to prevent atrial fibrillation recurrence
por: Youzheng Dong, et al.
Publicado: (2022-09-01)

Managing postoperative atrial fibrillation after open-heart surgery using transdermal β1 blockers
por: Kenji Yamamoto, et al.
Publicado: (2023-04-01)